A CPAP machine is a medical device often recommended to folks who have sleep apnea or other disruptive sleep conditions. Wearers place a mask over their nose and mouth to deliver a continuous stream ...
On Thursday, ResMed Inc (NYSE:RMD) reported first-quarter adjusted EPS of $2.20, up 34% year over year, beating the consensus of $2.04. The company reported sales of $1.224 billion, up 11%, beating ...
San Diego, California-based ResMed has received FDA 510(k) clearance for its small, portable continuous positive airway pressure (CPAP) device, the AirMini. The announcement was made during the JP ...
Connected sleep devicemaker ResMed today released the AirSense 11, its latest CPAP machine iteration, which includes a host of new features to treat obstructive sleep apnea. The new machine has many ...
Jan 30 (Reuters) - ResMed (RMD.N), opens new tab beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep ...
Jan 24 (Reuters) - ResMed (RMD.N), opens new tab beat Wall Street estimates for second-quarter revenue and profit on Wednesday, powered by strong demand for its respiratory devices used to treat sleep ...
Air Voel, a fast-growing Canadian provider of sleep therapy and respiratory care equipment, has announced the expansion of its nationwide distribution network for the highly in-demand ResMed AirSense ...
ResMed, Inc. RMD recently introduced its AirCurve 11 series devices. These are the company’s newest bilevel devices that use two levels of support, inspiratory positive airway pressure and expiratory ...
Amid a recall of its AirFit and AirTouch continuous positive airflow pressure (CPAP) devices, ResMed released its latest earnings report Wednesday afternoon. The San Diego-based medical device company ...
(Reuters) - Medical equipment maker ResMed reported fourth-quarter revenue in line with estimates on Thursday, on steady demand for its sleep apnea treatment devices. The company's quarterly revenue ...
Add Yahoo as a preferred source to see more of our stories on Google. (Reuters) - ResMed beat Wall Street estimates for quarterly profit on Wednesday due to strong demand for its sleep apnea devices, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results